Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9861705 Conjugates of an IL-2 moiety and a polymer

Patent 9861705 was granted and assigned to Nektar Therapeutics on January, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Nektar Therapeutics
Nektar Therapeutics
Date Filed
November 11, 2011
Date of Patent
January 9, 2018
Patent Application Number
13884901
Patent Citations Received
‌
US Patent 11999771 IL-7Rαγc ligand immunoglobulin fusion proteins
0
‌
US Patent 12091441 Partial agonists of interleukin-2
0
‌
US Patent 12076371 Activatable cytokine polypeptides and methods of use thereof
0
‌
US Patent 11701407 Cytokine conjugates for the treatment of proliferative and infectious diseases
0
‌
US Patent 11746139 IL-7Rαγc binding compounds
‌
US Patent 11981716 Activatable interleukin-2 polypeptides and methods of use thereof
0
‌
US Patent 11965015 IL-7R-α-γ binding compounds
0
Patent Inventor Names
Cherie F. Ali
0
Deborah H. Charych
0
Mary J. Bossard
0
Xiaofeng Liu
0
Yujun Wang
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9861705
Patent Primary Examiner
‌
Brian Gangle

Find more entities like US Patent 9861705 Conjugates of an IL-2 moiety and a polymer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.